TABLE 1.
Patient characteristicsa
| Characteristic | No. of:
|
|||||
|---|---|---|---|---|---|---|
| Reported cases | Cultures testing negative | Isolates included in analysis | Isolates excluded from analysis | Isolates with a high copy no. | Isolates with a low copy no. | |
| No. of patients | 527 | 55 | 431 | 41 | 347 | 84 |
| Median age (yr) (IQR) | 39 (28-63) | 33 (18-62) | 40 (29-63) | 39 (31-64) | 40 (29-64) | 39 (27-61.5) |
| No. female (%) | 241 (46) | 31 (56) | 195 (45) | 15 (37) | 155 (45) | 40 (48) |
| No. Canadian born (%) | 95 (19) | 13 (24) | 77 (18) | 7 (17) | 68 (20) | 9 (11) |
| Median time (yr) since migration (IQR) | 5 (1-13) | 3 (1-13) | 5 (2-13) | 4 (1-14) | 5 (1-14) | 6.5 (3-13) |
| No. with pulmonary disease (%) | 333 (63) | 36 (66) | 270 (63) | 27 (66) | 221 (64) | 49 (58) |
| No. susceptible to all drugs (%) | 400 (85) | NA | 370 (86) | 30 (77) | 297 (86) | 73 (87) |
a
Demographic and clinical characteristics of patients included in and excluded from the study. IQR, interquartile range; NA, not applicable.